Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |